Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR+14.8%
5Y CAGR-15.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+14.8%/yr
Annual compound
5Y CAGR
-15.6%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.16 | +15.1% |
| 2024 | 3.61 | -4.0% |
| 2023 | 3.76 | +37.0% |
| 2022 | 2.75 | -58.6% |
| 2021 | 6.63 | -31.9% |
| 2020 | 9.73 | +148.9% |
| 2019 | -19.91 | +53.7% |
| 2018 | -43.01 | - |